StonvexLoading…
StonvexStonvexStonvexCore line items from SNWV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 |
|---|---|---|---|---|
Revenue | $32.33M | $19.25M | $15.51M | $11.38M |
Operating Income | $3.85M | $-540.00K | $-8.95M | $-14.14M |
Net Income | $-33.08M | $-25.81M | $-10.29M | $-27.26M |
EPS (Diluted) | $-7.41 | $-12.19 | $-0.02 | $-0.05 |
Total Assets | $30.12M | $22.42M | $19.87M | $18.62M |
Total Liabilities | $45.91M | $65.59M | $60.88M | $57.58M |
Cash & Equivalents | $10.24M | $1.80M | $1.15M | $619.00K |
Free Cash Flow OCF − CapEx | $1.97M | $-4.54M | Not available | $-6.94M |
Shares Outstanding | 8.54M | 3.04M | 548.74M | 481.62M |